Expected prevalence of sheehan's syndrome in Mexico by extrapolation of screenings in other countries


  • Miriam Deyanira Rodríguez Piña Facultad de Medicina, Universidad Autónoma del Estado de México
  • Nohemi Piña Vidal Facultad de Medicina, Universidad Autónoma del Estado de México https://orcid.org/0000-0003-3449-3539
  • Betsy Corina Sosa García Facultad de Medicina, Universidad Autónoma del Estado de México
  • Pamela Lagos Robles Facultad de Medicina, Universidad Autónoma del Estado de México
  • Hugo Mendieta Zerón Facultad de Medicina, Universidad Autónoma del Estado de México https://orcid.org/0000-0003-3492-8950




Sheehan's syndrome, Prevalence, Mexico, Extrapolation


Background: Sheehan's syndrome (SS) occurs as result of ischemic pituitary necrosis due to postpartum hemorrhage; its prevalence in Mexico is unknown.
Objective: To estimate the approximate number of Mexican women that could have SS.
Methods: A search was performed in PubMed and Web of Science using the mesh terms: "postpartum hemorrhage" OR "Hypopituitarism". Besides these same keywords, in Google Scholar the search was expanded using the next terms: "Sheehan's syndrome prevalence". It was calculated the estimated cases of obstetric hemorrhage and the SS incidence in México based on casuistries from three countries.
Results: Extrapolating data from India, the total cases of SS in Mexico in the last five years could be as high as 322761 or about 2000 if taking Iceland’s statistics. As the measure of all the adenohypophyseal hormones is of 56 dollars in Mexican public institutions, the option to make and early SS diagnosis should be to quantify only TSH that has a cost of 13.5 dollars.
Conclusions: The prevalence of SS in Mexico can have a 161-fold difference between the minimum and maximum values calculated by extrapolating information from other countries, so it is important to consider screening alternatives such as TSH measurement for its detection.
Keywords: Hypopituitarism; Postpartum hemorrhage; Sheehan's syndrome; TSH


Não há dados estatísticos.


Kelestimur F, Tanriverdi F, Atmaca H, Unluhizarci K, Selcuklu A, Casanueva FF. Boxing as a sport activity associated with isolated GH deficiency. J Endocrinol Invest. 2004;27(11):RC28-32.

Atmaca H, Tanriverdi F, Unluhizarci kursad, Kelestimur F. Posterior pituitary function in Sheehan’s syndrome. Eur J Endocrinol. 2007;156(5):563.568.

Gei-Guardia O, Soto-Herrera E, Gei-Brealey A, Chen-Ku CH. Sheehan syndrome in Costa Rica: clinical experience with 60 cases. Endocr Pract. 2011;17(3):337-44.

Collins M, O’Brien P, Cline A. Diabetes insipidus following obstetric shock. Obstet Gynecol. 1979;53(3 Suppl):15S-17S.

Bunch T, WF Dunn, Basu A, Gosman R. Hyponatremia and hypoglycemia in acute Sheehan’s syndrome. Gynecol Endocrinol. 2002;16(5):419-23.

Huang Y, Lu Y, Huang Y-M, Wang M, Ling W, Sui Y, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism. 2020;113:154378.

Banzal S, Ayoola E, Banzal S. Sheehan’s syndrome in Saudi Arabia. Int J Gynaecol Obstet. 1999;66(2):181-92.

Regal M, Páramo C, Sierra S, Garcia-Mayor R. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001;55(6):735-40.

Sheehan H. Postpartum necrosis of the anterior pituitary. Am J Obstet Gynecol. 1971;111(6):189-214.

Asaoka K. [A study on the incidence of post-partum hypopituitarism, (Sheehan’s syndrome)]. Nihon Naibunpi Gakkai Zasshi. 1977;53(7):895-909.

Feinberg E, Molitch M, Endres L, Peaceman A. The incidence of Sheehan’s syndrome after obstetric hemorrhage. Fertil Steril. 2005;84(4):979-89.

Roy T, Kulkarni S, Pandey A, Gupta K. International Institute for Population Sciences (IIPS) and ORC Macro National Family Health Survey (NHFS-2) 1988-199. INDIA; 2000. https://www.dhsprogram.com/pubs/pdf/FRIND2/FRIND2.pdf

Tessnow A, Wilson J. The changing face of Sheehan’s syndrome. Am J Med Sci. 2010;340(5):402-6.

Nascimento FA, Nery J, Marques GL, Santos FD dos, Carvalho M de. A decade without diagnosis: Sheehan’s syndrome. Case Rep Clin Med. 2013;2(8):490-3.

Matsuwaki T, Khan KN, Inoue T, Yoshida A, Masuzaki H. Evaluation of obstetrical factors related to Sheehan syndrome. J Obstet Gynaecol Res. 2014;40(1):46-52.

Weeks A. The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next? BJOG. 2015;122(2):202-10.

Joseph K, Rouleau J, Kramer M, Young D, Liston R, Baskett T. Investigation of an increase in postpartum haemorrhage in Canada. BJOG. 2007;114(6):751-9.

Lain S, Roberts C, Hadfield R, Bell J, Morris J. How accurate is the reporting of obstetric haemorrhage in hospital discharge data? A validation study. Aust N Z J Obstet Gynaecol. 2008;48(5):481-94.

Lust K, McIntyre H, Morton A. Sheehan’s syndrome--acute presentation with hyponatraemia and headache. Aust N Z J Obstet Gynaecol. 2001;41(3):348-51.

Soares D, Conceição F, Vaisman M. [Clinical, laboratory and therapeutics aspects of Sheehan’s syndrome] - PubMed. Arq Bras Endocrinol Metabol. 2008;52(5):872-88.

Oliveira J, Persani L, Beck-Peccoz P, Abucham J. Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan’s syndrome: characterization of TSH carbohydrate content and bioactivity. J Clin Endocrinol Metab. 2001;86(4):1694-709.

Nillni E. Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Front Neuroendocrinol. 2010;31(2):134-56.

Shupnik M, Ridgway E, Chin W. Molecular biology of thyrotropin. Endocr Rev. 1989;10(4):459-75.

Magner JA. Thyroid-stimulating hormone: biosynthesis, cell biology, and bioactivity. Endocr Rev. 1990;11(2):354-85.

Joshi L, Bd W. Naturally occurring forms of thyrotropin with low bioactivity and altered carbohydrate content act as competitive antagonists to more bioactive forms. Endocrinology. 1983;113(6):2145-54.

Szkudlinski MW, Thotakura NR, Bucci I, Joshi LR, Tsai A, East-Palmer J, et al. Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity. Endocrinology. 1993;133(4):1490-503.

Pickardt CR, Scriba PC. TRH: Pathophysiologic and clinical implications. Acta Neurochir (Wien). 1985;75(1):43-8.

Jongejan RMS, van Velsen EFS, Meima ME, Klein T, van den Berg SAA, Massolt ET, et al. Change in Thyroid Hormone Metabolite concentrations across Different Thyroid States. Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0453.

Avramovska M, Kostova NM, Karanfilski B, Hunziker S, Vaskova O, Dimitrov G, et al. Thyroid Function of Pregnant Women and Perinatal Outcomes in North Macedonia. Rev Bras Ginecol Obstet. 2021;43(10):736-742.

Fernández-Lara JA, Toro-Ortiz JC, Martínez-Trejo Z, Maza-Labastida S de la, Villegas-Arias MA, Fernández-Lara JA, et al. Tasa de hemorragia, histerectomía obstétrica y muerte materna relacionada. Ginecol Obstet México. 85(4):247-53.

Ekin A, Gezer C, Solmaz U, Taner CE, Dogan A, Ozeren M. Predictors of severity in primary postpartum hemorrhage. Arch Gynecol Obstet. 2015;292(6):1247-54.

Kristjansdottir H, Bodvarsdottir S, Sigurjonsdottir H. Sheehan’s syndrome in modern times: a nationwide retrospective study in Iceland. Eur J Endocrinol. 2011;164(3):349-54.

Zargar A, Singh B, Laway B, Masoodi S, Wani A, Bashir M. Epidemiologic aspects of postpartum pituitary hypofunction (Sheehan’s syndrome). Fertil Steril. 2005;84(2):523-8.

Fernández S Laura, Viruez-Soto J A, Vera-Carrasco O. Panhipopituitarismo secundario a hemorragia obstétrica profusa. Cuad. - Hosp. Clín. 2020; 61(2):47-50.

Tanriverdi F, Dokmetas HS, Kebapcı N, Kilicli F, Atmaca H, Yarman S, et al. Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database. Endocrine. 2014;47(1):198-205.

Diri H, Tanriverdi F, Karaca Z, Senol S, Durak A, Atmaca H, et al. Extensive investigation of 114 patients with Sheehan’s syndrome: a continuing disorder. Eur J Endocrinol. 2014;171(3):311-8.

Famuyiwa OO, Bella AF, Akanji AO. Sheehan’s syndrome in a developing country, Nigeria: a rare disease or problem of diagnosis? East Afr Med J. 1992;69(1):40-3.

Azeez T, Esan A, Balogun W, Adeleye J, Temilola ak. Sheehan’s syndrome: A descriptive case series from a developing country. J Clin Mol Endocrinol. 2020;5(1):1-3.

INEGI. Natalidad y fecundidad. 2021. Available from: https://www.inegi.org.mx/temas/natalidad/

Goswami R, Kochupillai N, Crock PA, Jaleel A, Gupta N. Pituitary Autoimmunity in Patients with Sheehan’s Syndrome. J Clin Endocrinol Metab. 2002;87(9):4137-41.

Chávez CMC, Castillo LM, Gaitán PBM, Domínguez AP, Mendoza PEC. Síndrome de Sheehan. Descripción de un caso clínico y revisión de la literatura. Arch Med Urgenc México. 2013;5(1):38-41.

Genetu A, Anemen Y, Abay S, Bante SA, Mihrete KM. A 45-year-old female patient with Sheehan’s syndrome presenting with imminent adrenal crisis: a case report. J Med Case Reports. 2012;15(1):1-5.

Honegger J, Giese S. Acute pituitary disease in pregnancy: how to handle hypophysitis and Sheehan's syndrome. Minerva Endocrinol. 2018;43(4):465-475.

Shivaprasad C. Sheehan's syndrome: Newer advances. Indian J Endocrinol Metab. 2011;15 Suppl 3(Suppl3):S203-S207.

Karaca Z, Laway BA, Dokmetas HS, Atmaca H, Kelestimur F. Sheehan syndrome. Nat Rev Dis Primer. 2016;2(1):1-15.

Instituto Politécnico Nacional (IPN). La Unidad de Servicios Externos e Investigación Clínica (USEIC). Catálogo de Pruebas de Laboratorio. Available from: https://useic.com.mx/tienda/estudios-sangre/perfil-hipofisiario-acth-matutina-hormona-de-crecimiento-fsh-lh-prl-tsh/

Consejo Nacional de Evaluación de la Política de Desarrollo Social (CONEVAL). Medición de la pobreza. Available from: https://www.coneval.org.mx/Medicion/MP/Paginas/Pobreza_2020.aspx

Laboratorio Médico del Chopo. Available from: https://www.chopo.com.mx/puebla/estudios/laboratorio?p=11&product_list_order=price



Como Citar

Rodríguez Piña, M. D., Piña Vidal, N., Sosa García, B. C., Lagos Robles, P., & Mendieta Zerón, H. (2022). Expected prevalence of sheehan’s syndrome in Mexico by extrapolation of screenings in other countries. Revista Angolana De Ciências Da Saúde / Angolan Journal Of Health Sciences, 3(1), 10–16. https://doi.org/10.54283/RACSaude.v3i1.2022.p10-16



Artigo de Revisão / Review Article